TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
133.30
-5.99 (-4.30%)
At close: Feb 11, 2026, 4:00 PM EST
133.80
+0.50 (0.38%)
After-hours: Feb 11, 2026, 5:19 PM EST
TransMedics Group Revenue
TransMedics Group had revenue of $143.82M in the quarter ending September 30, 2025, with 32.24% growth. This brings the company's revenue in the last twelve months to $566.35M, up 41.20% year-over-year. In the year 2024, TransMedics Group had annual revenue of $441.54M with 82.74% growth.
Revenue (ttm)
$566.35M
Revenue Growth
+41.20%
P/S Ratio
7.96
Revenue / Employee
$777,959
Employees
728
Market Cap
4.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 441.54M | 199.92M | 82.74% |
| Dec 31, 2023 | 241.62M | 148.16M | 158.53% |
| Dec 31, 2022 | 93.46M | 63.20M | 208.83% |
| Dec 31, 2021 | 30.26M | 4.62M | 18.03% |
| Dec 31, 2020 | 25.64M | 2.04M | 8.62% |
| Dec 28, 2019 | 23.60M | 10.59M | 81.33% |
| Dec 29, 2018 | 13.02M | 5.33M | 69.38% |
| Dec 30, 2017 | 7.69M | -5.33M | -40.96% |
| Dec 31, 2016 | 13.02M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bruker | 3.44B |
| Bio-Rad Laboratories | 2.56B |
| Bio-Rad Laboratories | 2.56B |
| Masimo | 2.18B |
| Integer Holdings | 1.83B |
| LivaNova | 1.35B |
| Haemonetics | 1.32B |
| Alphatec Holdings | 728.02M |
TMDX News
- 1 day ago - TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - PRNewsWire
- 2 days ago - TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial - PRNewsWire
- 8 days ago - TransMedics: Italian NOP Program Reinforces Huge International Opportunity - Seeking Alpha
- 9 days ago - These 10 Stocks Could Be Short Squeeze Targets: Lucid, Kohl's, Avis and More - Benzinga
- 27 days ago - These under-the-radar stocks combine fast growth with big upside potential - Market Watch
- 4 weeks ago - TransMedics: Strong Growth And A Better Setup - Seeking Alpha
- 4 weeks ago - TransMedics Group, Inc. (TMDX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts - PRNewsWire